The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Cimeldine 400 mg Film-coated tablets

Clonmel Healthcare LtdPA0126/077/002

Main Information

Trade NameCimeldine 400 mg Film-coated tablets
Active SubstancesCimetidine
Dosage FormFilm-coated tablet
Licence HolderClonmel Healthcare Ltd
Licence NumberPA0126/077/002

Group Information

ATC CodeA02BA H2-receptor antagonists
A02BA01 cimetidine


License statusAuthorised
Licence Issued06/11/1989
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back